Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin

Chunyun Pu; Shaorong Tian; Sanxiu He; Weihong Chen; Yuanyuan He; Hongyan Ren; Jing Zhu; Jun Tang; Xiaolan Huang; Ying Xiang; Yixiao Fu; Tingxiu Xiang

doi:10.1016/j.gendis.2020.11.013

您当前的位置：

首页 >

文章列表页 >

Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin

更新时间：2022-06-24

- Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin
- Genes & Diseases Vol. 9, Issue 4, (2022)
- 作者机构：
  
  1. Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University,Chongqing,PR China,400016
  2. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University,Chongqing,PR China,400016
  3. Department of Urinary Surgery, The First Affiliated Hospital of Chongqing Medical University,Chongqing,PR China,400016
  4. Department of Oncology, The First Affiliated Hospital of Chongqing Medical University,Chongqing,PR China,400016
  5. Ph.D Research Center for Medical and Social Development, Chongqing Medical University,Chongqing,PR China,400016
  6. Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University,Chongqing,PR China,400016
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2020.11.013
  CLC：
- Published：2022，
  
  Published Online：1 July 2022，
扫描看全文
Chunyun Pu, Shaorong Tian, Sanxiu He, et al. Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin. [J]. Genes & Diseases 9(4).(2022)
DOI：

Chunyun Pu, Shaorong Tian, Sanxiu He, et al. Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin. [J]. Genes & Diseases 9(4).(2022) DOI： 10.1016/j.gendis.2020.11.013.

摘要

Abstract

Recent studies suggest that Hypocretin (HCRT

Orexin) are involved in stress regulation of depression through the hypothalamic-pituitary-adrenal (HPA) axis. However

the molecular mechanism by which Hypocretin regulate neurobiological responses is unknown. Herein

the effects of chronic stress on the epigenetic modification of HCRT and its association with depression were explored with regard to a potential role in cancer progression. In the study

Sprague Dawley (SD) rats were used to establish an animal model of cancer with depression by administrating n-nitrosodiethylamine (DEN) and chronic unpredictable mild stress (CUMS). RNA-sequencing was used to detect differentially expressed genes in the hippocampus of rats and quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate the results of RNA-sequencing. The status of HCRT promoter methylation was assessed by methylation specific polymerase chain reaction. Behavioral tests showed that rats exposed to CUMS had significant depressive-like behaviors. The number of liver tumors and tumor load in depressed rats exposed to CUMS was higher than in SD rats without CUMS. RNA-sequencing revealed that HCRT was one of the most siginificantly downregulated gene in the hippocampus of SD rats with CUMS compared to non-stressed group

which was validated by qRT-PCR. HCRT mRNA expression was downregulated and the promoter for HCRT was hyper-methylated in those with depression. These results identified a critical role for chronic psychological stressors in tumorigenesis and cancer progression

via epigenetic HCRT downregulation. Such epigenetic downregulation may be the molecular basis for the association of cancer with depression.

关键词

Keywords

CancerChronic unpredictability mild stressCpG methylationDepressionHypocretin

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

De novo nucleotide biosynthetic pathway and cancer

Multiple regulatory roles of the transfer RNA-derived small RNAs in cancers

The generation and use of animal models of osteosarcoma in cancer research

The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities

Synthetic lethal approaches to target cancers with loss of PTEN function

Related Author

Jie Chen

Siqi Yang

Yingge Li

Xu Ziwen

Pingfeng Zhang

Qibin Song

Yi Yao

Huadong Pei

Related Institution

Cancer Center, Renmin Hospital of Wuhan University

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center,,.C.

Department of Medical Oncology, Affiliated Hospital of Nantong University

Medical School of Nantong University, Nantong University

Research Center of Clinical Medicine, Affiliated Hospital of Nantong University

⁰